表紙
市場調查報告書

動物用成長促進劑、增強劑的全球市場預測 2024年:抗生素及非抗生素 (荷爾蒙、酸化劑、飼料用酵素、益生菌&益生元、植物性添加物)

Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 923638
出版日期 內容資訊 英文 161 Pages
訂單完成後即時交付
價格
動物用成長促進劑、增強劑的全球市場預測 2024年:抗生素及非抗生素 (荷爾蒙、酸化劑、飼料用酵素、益生菌&益生元、植物性添加物) Animal Growth Promoters and Performance Enhancers Market by Product Antibiotic and Non-antibiotic (Hormones, Acidifiers, Feed Enzymes, Probioitcs & Prebiotics, Phytogenics), Animal (Poultry, Porcine, Livestock, Aquaculture) - Global Forecast to 2024
出版日期: 2020年01月22日內容資訊: 英文 161 Pages
簡介

全球動物用成長促進劑、增強劑市場規模預測將從2019年的139億美元,到2024年達到185億美元。促進該市場的成長的主要原因,是肉類需求的增加,抗生素的替代品的研究,及應對傳染病、環境要素的必要性。可是,在各國對抗生素及特定的成長促進劑設置嚴格法規,影響動物用成長促進劑、增強劑的採用。各地區中,預計歐洲市場在預測期間內記錄最大的成長。由於國內的家畜,家禽及豬肉生產量的增加,歐洲對特定的成長促進劑的禁止造成肉類進口的減少等要素,促進歐洲的動物用成長促進劑、增強劑的成長。還有其他的因素,是歐洲地區的動物生產的技術進步和肉類生產量的增加。

本報告提供全球動物用成長促進劑、增強劑市場相關調查分析,類型,動物種類,及各地區今後供需的變化預測,市場發展的影響要素,競爭環境,主要企業等相關的調查、分析資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 動物用成長促進劑、增強劑市場概要
  • 亞太地區的動物用成長促進劑、增強劑市場:各類型
  • 動物用成長促進劑、增強劑市場地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 動物用成長促進劑、增強劑市場:各類型

  • 簡介
  • 非抗生素的成長促進劑、增強劑
    • 益生元、益生菌
    • 酸化劑
    • 植物性添加物
    • 飼料用酵素
    • 荷爾蒙
    • 其他
  • 抗生素成長促進劑
    • 由於不利的法規、使用禁止而慢慢減少

第7章 動物用成長促進劑、增強劑市場:各動物種類

  • 簡介
  • 家禽
  • 家畜
  • 水生動物
  • 其他

第8章 動物用成長促進劑、增強劑市場:各地區

  • 簡介
  • 亞太地區
  • 北美
  • 歐洲
  • 其他

第9章 競爭情形

  • 簡介
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭模式

第10章 汽車用燃料電池市場:各H2燃料站

  • CARGILL, INC.
  • ROYAL DSM N.V.
  • ELANCO ANIMAL HEALTH INC.
  • MERCK & CO., INC.
  • ALLTECH, INC.
  • ARCHER-DANIELS-MIDLAND COMPANY (ADM)
  • VETOQUINOL
  • BUPO ANIMAL HEALTH
  • CHR. HANSEN
  • NOVUS INTERNATIONAL, INC.
  • ASSOCIATED BRITISH FOODS PLC
  • ERBER AG
  • PHIBRO ANIMAL HEALTH CORPORATION
  • KEMIN INDUSTRIES
  • NUTRECO (A WHOLLY OWNED SUBSIDIARY OF SHV GROUP)
  • BASF SE
  • LALLEMAND INC.
  • BLUESTAR ADISSEO COMPANY
  • EVONIK INDUSTRIES AG
  • LAND O'LAKES, INC.

第11章 附錄

目錄
Product Code: BT 4276

"The animal growth promoters and performance enhancers market projected to grow at a CAGR of 5.9% during the forecast period (2019-2024)."

The global animal growth promoters and performance enhancers market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9% during the forecast period. The key factors driving the growth of this market is the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.

"By type, the non-antibiotic growth promoters segment is expected to grow at the highest CAGR during the forecast period (2019-2024)."

On the basis of type, the market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment commanded the largest share of the animal growth promoters and performance enhancers market in 2018. This large share of this segment is due to the economic benefits, a wide range of substances (acidifiers, prebiotics & probiotics, feed enzymes, phytogenic, hormones and others growth promoters), numerous applications in various production animals, greater sustainability, and the increasing number of regulations on antibiotics.

"By animal type, the poultry segment is expected to dominate the market during the forecast period (2019-2024)."

Based on animal type, the market is segmented into poultry, porcine, livestock, aquaculture, and other animals (equine, rabbit, camel, deer, yak, and geese). The poultry segment marked the largest share of the animal growth promoters and performance enhancers market in 2018. The large market share of this segment can be attributed to the increasing demand for poultry meat & eggs, novel diet approaches, and antibiotics phase-outs, resulting in the development of alternatives.

"The Europe region to witness the highest growth during the forecast period (2019-2024)."

The Europe market is projected to register the highest growth during the forecast period. Factors such as rising in domestic livestock, poultry and pork production, and decreasing meat imports owing to the ban of certain growth promoters in Europe are driving the growth for the animal growth promoters and performance enhancers market in Europe. Other factors also include technological advancements in animal production in this region and increasing meat production.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-21%, Tier 2-26%, and Tier 3-53%
  • By Designation: C-level-32%, Director-level-23%, and Others-45%
  • By Region: North America-36%, Europe-32%, Asia Pacific-17%, RoW-15%

Prominent players in the global animal growth promoters and performance enhancers market include are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N. V. (Germany), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Alltech Inc. (US), Phibro Animal Health Corporation (US), Kemin Industries (US), and SHV (Nutreco) (UK).

Research Coverage:

The report analyzes the animal growth promoters and performance enhancers market and aims at estimating the market size and future growth potential of this market based on various segments such as product, animal type, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or any combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the animal growth promoters and performance enhancers market. The report analyzes the market based on the product, animal type, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the animal growth promoters and performance enhancers market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various animal growth promoters and performance enhancers equipment across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the animal growth promoters and performance enhancers market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the animal growth promoters and performance enhancers market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
  • 1.4 YEARS CONSIDERED FOR THE STUDY
  • 1.5 CURRENCY
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.3 DATA TRIANGULATION
  • 2.4 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE (2018)
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Continuous growth in the global meat demand
      • 5.2.1.2 Research into alternatives to antibiotics and hormones and increasing demand for non-antibiotic growth promoters
      • 5.2.1.3 Rise in animal epidemics and climate changes
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Stringent regulations restricting the use of antibiotics and hormones for growth promotion in animals
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Focus on increasing environment sustainability
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing global feed tonnage and high feed costs leading to the adoption of conventional feeding systems

6 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
    • 6.2.1 PREBIOTICS & PROBIOTICS
      • 6.2.1.1 Prebiotics & probiotics hold the largest share of the market
    • 6.2.2 ACIDIFIERS
      • 6.2.2.1 Regulations on antibiotics and wide applications in different production animals have driven the use of acidifiers
    • 6.2.3 PHYTOGENICS
      • 6.2.3.1 Natural performance enhancement and antioxidative & disease defense properties have supported the use of phytogenics
    • 6.2.4 FEED ENZYMES
      • 6.2.4.1 Feed enzymes segment is expected to benefit greatly from the bans of antibiotics and hormones
    • 6.2.5 HORMONES
      • 6.2.5.1 Human health implications and restricted usage due to regulations will hamper the growth of the hormones segment
    • 6.2.6 OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
  • 6.3 ANTIBIOTIC GROWTH PROMOTERS
    • 6.3.1 ANTIBIOTICS TO FACE A GRADUAL DECLINE DUE TO UNFAVORABLE REGULATIONS AND BANS ON THEIR USE

7 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE

  • 7.1 INTRODUCTION
  • 7.2 POULTRY
    • 7.2.1 IN 2018, THE POULTRY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
  • 7.3 SWINE
    • 7.3.1 RISING DEMAND FOR PORK MEAT AND INCREASING AWARENESS OF AFRICAN SWINE FEVER (ASF) OUTBREAKS TO DRIVE THE ADOPTION OF GROWTH PROMOTERS AND PERFORMANCE ENHANCERS
  • 7.4 LIVESTOCK
    • 7.4.1 THE LIVESTOCK SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • 7.5 AQUATIC ANIMALS
    • 7.5.1 GROWING PRODUCTION AND CONSUMPTION OF SEAFOOD TO DRIVE THE DEMAND FOR GROWTH PROMOTERS FOR AQUATIC ANIMALS
  • 7.6 OTHER ANIMALS

8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 ASIA PACIFIC
    • 8.2.1 CHINA
      • 8.2.1.1 China dominates the APAC animal growth promoters and performance enhancers market
    • 8.2.2 INDIA
      • 8.2.2.1 Large livestock population and increasing production and export capacities to drive market growth in the country
    • 8.2.3 JAPAN
      • 8.2.3.1 Rising domestic meat demand and government efforts to encourage animal producers are driving the demand for promoters in Japan
    • 8.2.4 AUSTRALIA
      • 8.2.4.1 Large cattle population and heavy meat exports have supported the market in Australia
    • 8.2.5 REST OF ASIA PACIFIC
      • 8.2.5.1 Lack of a defined regulatory scenario has resulted in the wide use of antibiotic growth promoters in the RoAPAC
  • 8.3 NORTH AMERICA
    • 8.3.1 US
      • 8.3.1.1 US holds the largest share of the North American market
    • 8.3.2 CANADA
      • 8.3.2.1 Canada is a prominent meat and aquaculture producer and exporter
  • 8.4 EUROPE
    • 8.4.1 RUSSIA
      • 8.4.1.1 Russia holds the largest share of the European market
    • 8.4.2 REST OF EUROPE
      • 8.4.2.1 Technological advancements and the strong trade industry have supported the RoE market
  • 8.5 REST OF THE WORLD
    • 8.5.1 BRAZIL
      • 8.5.1.1 Brazil dominates the RoW market for animal growth promoters and performance enhancers
    • 8.5.2 REST OF LATIN AMERICA
      • 8.5.2.1 Strong demand for animal products and supportive initiatives have supported the market in the RoLA
    • 8.5.3 MIDDLE EAST
      • 8.5.3.1 Increasing demand for chicken and seafood have contributed to market growth in the Middle East
    • 8.5.4 AFRICA
      • 8.5.4.1 Reliance on conventional livestock production practices may hamper the market growth in Africa

9 COMPETITIVE LANDSCAPE

  • 9.1 INTRODUCTION
  • 9.2 MARKET SHARE ANALYSIS
  • 9.3 COMPETITIVE LEADERSHIP MAPPING (2018)
    • 9.3.1 VISIONARY LEADERS
    • 9.3.2 INNOVATORS
    • 9.3.3 DYNAMIC DIFFERENTIATORS
    • 9.3.4 EMERGING COMPANIES
  • 9.4 COMPETITIVE SCENARIO
    • 9.4.1 KEY DEVELOPMENTS IN THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
    • 9.4.2 KEY PRODUCT LAUNCHES
    • 9.4.3 KEY ACQUISITIONS
    • 9.4.4 KEY EXPANSIONS

10 COMPANY PROFILES

(Business overview, Products offered, Recent developments & Competitive Analysis)*

  • 10.1 CARGILL, INC.
  • 10.2 ROYAL DSM N.V.
  • 10.3 ELANCO ANIMAL HEALTH INC.
  • 10.4 MERCK & CO., INC.
  • 10.5 ALLTECH, INC.
  • 10.6 ARCHER-DANIELS-MIDLAND COMPANY (ADM)
  • 10.7 VETOQUINOL
  • 10.8 BUPO ANIMAL HEALTH
  • 10.9 CHR. HANSEN
  • 10.10 NOVUS INTERNATIONAL, INC.
  • 10.11 ASSOCIATED BRITISH FOODS PLC
  • 10.12 ERBER AG
  • 10.13 PHIBRO ANIMAL HEALTH CORPORATION
  • 10.14 KEMIN INDUSTRIES
  • 10.15 NUTRECO (A WHOLLY OWNED SUBSIDIARY OF SHV GROUP)
  • 10.16 BASF SE
  • 10.17 LALLEMAND INC.
  • 10.18 BLUESTAR ADISSEO COMPANY
  • 10.19 EVONIK INDUSTRIES AG
  • 10.20 LAND O'LAKES, INC.

Details on Business overview, Products offered, Recent developments & Competitive Analysis might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1 PER CAPITA MEAT CONSUMPTION OF LIVESTOCK PRODUCTS
  • TABLE 2 BANS ON ANTIBIOTICS AND HORMONES, BY COUNTRY AND YEAR
  • TABLE 3 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 4 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 5 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8 APAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9 ROW: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10 PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11 NORTH AMERICA: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12 EUROPE: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13 APAC: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14 ROW: PREBIOTIC & PROBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15 ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 16 NORTH AMERICA: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17 EUROPE: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18 APAC: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19 ROW: ACIDIFIER GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20 PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 21 NORTH AMERICA: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22 EUROPE: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 23 APAC: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24 ROW: PHYTOGENIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25 FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26 NORTH AMERICA: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27 EUROPE: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28 APAC: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 29 ROW: FEED ENZYME GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30 HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 31 NORTH AMERICA: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 32 EUROPE: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33 APAC: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34 ROW: HORMONAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35 OTHER NON-ANTIBIOTIC ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36 NORTH AMERICA: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37 EUROPE: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38 APAC: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39 ROW: OTHER NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40 PERCENTAGE SALES OF ANTIMICROBIAL SUBSTANCES IN THE US, 2017
  • TABLE 41 ANTIBIOTICS BANS & REGULATIONS, BY COUNTRY
  • TABLE 42 ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43 NORTH AMERICA: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44 EUROPE: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45 APAC: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46 ROW: ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 48 WORLD'S TOP 15 COUNTRIES THAT EXPORTED FRESH OR CHILLED CHICKEN DURING 2018
  • TABLE 49 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR POULTRY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 50 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR SWINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 51 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, FOR LIVESTOCK, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 52 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR AQUATIC ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET FOR OTHER ANIMALS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 54 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 57 ASIA PACIFIC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 58 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 59 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 60 CHINA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 61 CHINA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 62 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 63 INDIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 64 INDIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 65 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 66 JAPAN: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 67 JAPAN: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 68 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 69 AUSTRALIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 70 AUSTRALIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 71 REGULATORY SCENARIO FOR ANTIBIOTICS IN THE ROAPAC, BY COUNTRY
  • TABLE 72 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73 ROAPAC: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 74 ROAPAC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 75 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 76 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 77 NORTH AMERICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 78 NORTH AMERICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 79 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 80 US: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 81 US: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 82 BEEF AND VEAL EXPORTS BY CANADA BETWEEN OCTOBER 2018 AND OCTOBER 2019
  • TABLE 83 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84 CANADA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85 CANADA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 86 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 87 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 88 EUROPE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 89 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 90 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91 RUSSIA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92 RUSSIA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 93 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 94 ROE: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95 ROE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 96 ROW: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 97 ROW: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98 ROW: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 99 ROW: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 100 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101 BRAZIL: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102 BRAZIL: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 103 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104 ROLA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 105 ROLA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 106 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107 MIDDLE EAST: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 108 MIDDLE EAST: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 109 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110 AFRICA: NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111 AFRICA: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2017-2024 (USD MILLION)
  • TABLE 112 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016-2019)
  • TABLE 113 PRODUCT LAUNCHES (2016-2019)
  • TABLE 114 ACQUISITIONS (2016-2019)
  • TABLE 115 EXPANSIONS (2016-2019)

LIST OF FIGURES

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 4 MARKET SIZE ESTIMATION: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
  • FIGURE 5 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 7 NON-ANTIBIOTIC GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 8 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET, BY ANIMAL TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
  • FIGURE 10 CONTINUOUS GROWTH IN THE GLOBAL MEAT DEMAND TO DRIVE MARKET GROWTH
  • FIGURE 11 NON-ANTIBIOTIC GROWTH PROMOTERS ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 2018
  • FIGURE 12 EUROPE TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 13 ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14 ASIA PACIFIC WILL DOMINATE THE ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15 ASIA PACIFIC: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
  • FIGURE 16 EUROPE: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET SNAPSHOT
  • FIGURE 17 VALUE-BASED MARKET SHARES OF KEY PLAYERS, 2018
  • FIGURE 18 COMPETITIVE LEADERSHIP MAPPING: ANIMAL GROWTH PROMOTERS AND PERFORMANCE ENHANCERS MARKET
  • FIGURE 19 ROYAL DSM N.V.: COMPANY SNAPSHOT
  • FIGURE 20 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 21 MERCK & CO. INC.: COMPANY SNAPSHOT
  • FIGURE 22 ARCHER-DANIELS-MIDLAND COMPANY: COMPANY SNAPSHOT
  • FIGURE 23 CHR. HANSEN: COMPANY SNAPSHOT
  • FIGURE 24 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
  • FIGURE 25 PHIBRO ANIMAL HEALTH CORPORATION: COMPANY SNAPSHOT